This is a Validated Antibody Database (VAD) review about human GPD1, based on 2 published articles (read how Labome selects the articles), using GPD1 antibody in all methods. It is aimed to help Labome visitors find the most suited GPD1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
GPD1 synonym: GPD-C; GPDH-C; HTGTI; glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic; glycerol-3-phosphate dehydrogenase 1 (soluble); glycerol-3-phosphate dehydrogenase [NAD+], cytoplasmic; glycerophosphate dehydrogenase

Santa Cruz Biotechnology
mouse monoclonal (E-7)
  • western blot; human; fig 8e
Santa Cruz Biotechnology GPD1 antibody (Santa Cruz, sc-376219) was used in western blot on human samples (fig 8e). Oncotarget (2017) ncbi
Invitrogen
rabbit polyclonal
  • western blot; rat
In order to examine the effect of PPARalpha agonist administration on hepatic AQP9 expression and enzymes involved in glycerol metabolism, Invitrogen GPD1 antibody (Pierce, PA5-31051) was used in western blot on rat samples . Am J Physiol Gastrointest Liver Physiol (2015) ncbi
Articles Reviewed
  1. Zhou C, Yu J, Wang M, Yang J, Xiong H, Huang H, et al. Identification of glycerol-3-phosphate dehydrogenase 1 as a tumour suppressor in human breast cancer. Oncotarget. 2017;8:101309-101324 pubmed publisher
  2. Lebeck J, Cheema M, Skowronski M, Nielsen S, Praetorius J. Hepatic AQP9 expression in male rats is reduced in response to PPARα agonist treatment. Am J Physiol Gastrointest Liver Physiol. 2015;308:G198-205 pubmed publisher